News

View all
Thumbnail image for 75 projects to receive £1bn in NHS services upgrade

75 projects to receive £1bn in NHS services upgrade

Health and Social Care secretary Matt Hancock has announced that £1 billion of funding will go to as many as 75 projects across England to upgrade facilities and treat more patients, including mental health and new integrated care services in the community.

18th December 2018

Thumbnail image for Private firms receive £26m from tight NHS budget

Private firms receive £26m from tight NHS budget

The British Medical Association (BMA) has reported that private consultancy firms have been paid at least £26 million by the NHS as part of plans to reorganise the health service.

18th December 2018

Thumbnail image for Astellas, Sunovion and Shield breach ABPI Code

Astellas, Sunovion and Shield breach ABPI Code

The​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ Prescription Medicines Code of Practice Authority (PMCPA) has announced that Astellas, Sunovion and Shield Therapeutics have all breached the Association of the British Pharmaceutical Industry's Code of Practice.

18th December 2018

Web Exclusives

View all
Thumbnail image for Winning the battle for tech talent

Winning the battle for tech talent

Excitement around the transformative potential of AI and machine learning continues to build. Companies will need to adapt their individual offers to draw in AI specialists, but as an industry UK pharma should also continue to champion itself and the unique career advantages it holds for the best and brightest researchers.

Thumbnail image for NIHR welcomes Life Sciences Sector Deal 2

NIHR welcomes Life Sciences Sector Deal 2

Professor Chris Whitty, chief scientific adviser for the Department of Health and Social Care (DHSC), on the role of the NIHR and the promise of the government's second sector deal for the life sciences industry.

Thumbnail image for Adapting to the challenge

Adapting to the challenge

Mark Toms, chief scientific officer at Novartis Pharmaceuticals UK, looks at how to address the challenges of recruiting for Alzheimer’s prevention studies.

Thumbnail image for Orphan drug development and the urgent need for a new approach

Orphan drug development and the urgent need for a new approach

There are around 7,000 rare diseases for which there currently exists no authorised or satisfactory method of treatment, highlighting a vast area of unmet need, and yet the clinical development of orphan drugs is still fraught with many practical challenges.

Thumbnail image for Difficult divorce

Difficult divorce

The UK's exit from the EU will bring disruption to the pharma industry in 2019 – and any upside will remain in the future

Thumbnail image for AI is not new

AI is not new

...But this year its impact, and the potential for change, was felt across the pharma industry

Thumbnail image for 2018 – a slow year for M&A?

2018 – a slow year for M&A?

The value and volume of deals in H1 were higher than in the full year 2017, but a slow second half puts us a long way off 2015’s records

Thought Leadership

View all

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download